Manufacturing

SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China

Biopharmaceutical company SciNeuro Pharmaceuticals has signed an exclusive license agreement with Eli Lilly and Company for the development and commercialisation of alpha-synuclein targeted antibody therapies in Greater China.

Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806

Biogen and Bio-Thera Solutions have entered into a commercialisation and license agreement for the development, manufacturing and commercialisation of BAT1806.

Piramal to acquire APIs manufacturer Hemmo Pharmaceuticals

Piramal Pharma (PPL), a subsidiary of Piramal Enterprises, has agreed to acquire 100% stake in Indian peptide APIs manufacturer Hemmo Pharmaceuticals, for $105.6m (INR7.75bn).

Anima signs new strategic collaboration deal with Takeda

Anima Biotech has announced its new strategic collaboration deal with Takeda Pharmaceutical Company for the discovery and development of new medicines to combat genetically defined neurological diseases.

Boston Pharmaceuticals signs three-year agreement with GSK

The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK).

Moderna to boost global Covid-19 vaccine manufacturing capacity

Moderna has announced plans to increase its global manufacturing capacity for Covid-19 vaccine by making additional capital investments.

AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability

Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.

Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US

Ocugen, a Pennsylvania-based pharmaceutical company, has signed an agreement with Bharat Biotech, an Indian pharma developer of COVAXIN, a Covid-19 vaccine, to distribute the vaccine in the US.

WuXi STA to buy Swiss pharma manufacturing facility from Bristol Myers Squibb

WuXi STA, a subsidiary of Chinese pharmaceutical company WuXi AppTec, has agreed to buy the Couvet, Switzerland-based manufacturing facility from Bristol Myers Squibb.